Key result
A 14-day treatment with resveratrol reversed age-related impairment in endothelium-dependent vasodilation in mesenteric arteries and partially normalized adrenal medullary hyperactivity in aged rats.
Why the study?
Does resveratrol improve age-impaired endothelium-dependent vasodilation and adrenomedullary hyperactivity in male rats?
Does resveratrol improve age-impaired endothelium-dependent vasodilation and adrenomedullary hyperactivity in male rats?
p-value: p=<0.05
In an aging rat model, resveratrol reverses age-related endothelial dysfunction in mesenteric arteries and normalizes sympathetic hyperactivity.
Resveratrol may improve endothelial and sympathetic function in aged rats; hypothesis-generating and should not yet change practice.
PURPOSE: To determine whether resveratrol improves the adverse effects age on vascular function in mesenteric arteries (MAs), and diminishes the hyperactivity in adrenal gland with age. METHODS: Male F344 x Brown Norway rats were assigned to 6-month control (YC), 6-month resveratrol (YR), 24-month control (OC) and 24-month resveratrol (OR). Resveratrol (15 mg/kg) was provided to resveratrol groups in drinking water for 14 days. RESULTS: Concentration response curves to phenylephrine (PE, 10(-9)-10(-5)M), acetylcholine (Ach, 10(-9)-10(-5)M) and resveratrol (10(-8)-10(-4)M) were evaluated in pressurized isolated MAs. The Ach concentration-response curve was right shifted with maximal response diminished in OC compared with YC rats. These effects were reversed by resveratrol treatment. The resveratrol-mediated relaxant responses were unchanged with age or resveratrol suggesting an endothelium-independent mechanism. Resveratrol tended to increase endothelial nitric oxide synthase; caused no effect on copper-zinc superoxide dismutase; and normalized the age-related elevatation in DβH and NPY levels in adrenal medulla, two indicators of sympathetic activity. CONCLUSION: These data indicate that resveratrol reverses age-related dysfunction in endothelium-dependent vasodilation in MAs and partially reverses hyperactivity of adrenomedullary function with age. This treatment may have a therapeuticpotential in the treatment of cardiovascular diseases or hypertension in the elderly.
No takes yet. Share an insight, caveat, or question.
Göçmez et al. (2016) studied Age-related vascular dysfunction (n=32). Resveratrol vs. Vehicle (drinking water) was evaluated on Acetylcholine-mediated relaxant responses in mesenteric arteries (p=<0.05). A 14-day treatment with resveratrol reversed age-related impairment in endothelium-dependent vasodilation in mesenteric arteries and partially normalized adrenal medullary hyperactivity in aged rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: